Metraipolis › archive › dc_5e90b657d48e

Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41488627
DOI
10.3389/fimmu.2025.1718321
License (as archived)
solo-consultazione
Archived
2026-11-07T13:11:16.299Z
SHA-256 of the archived text
442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f
Stable URL of this page
https://metraipolis.com/documento/dc_5e90b657d48e

How to cite

Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627 — Europe PMC (en), https://europepmc.org/article/MED/41488627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e90b657d48e (Metraipolis archive dc_5e90b657d48e, sha256 442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f)
BibTeX
@misc{dc5e90b657d48e,
  title = {Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e90b657d48e; sha256 442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488627. Agents can read the archived copy with the MCP tool read_document.